Corneal Implants Market Analysis

  • Report ID: 4132
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT

Corneal Implants Segmentation

The corneal implants market is segmented by transplant type into anterior lamellar keratoplasty, penetrating keratoplasty, and endothelial keratoplasty, out of which, the endothelial keratoplasty segment is anticipated to hold the largest share of the market over the forecast period. For instance, in the United States, over 30,000 endothelial keratoplasties were performed in 2021. It is a common method for the treatment of Fuchs’ dystrophy, which is prevalent among the geriatric population. Moreover, this method helps in faster and better visual restoration with decreased risk of infection and accidents to the eye surface, which is also a factor expected to propel the growth of the segment.

On the basis of tissue type, the market is segmented into artificial cornea and human donor cornea, between which artificial cornea segment is estimated to witness fastest growth during the forecast period owing to the shortage of donor tissue. In addition to that, increasing bio-engineered artificial corneas and innovative procedures for artificial corneal crafting are further expected to drive the growth of the segment.

Our in-depth analysis of the global market includes the following segments:

           Tissue Type

  • Artificial Cornea
  • Human Donor Cornea

             Transplant Type

  • Anterior Lamellar Keratoplasty
  • Penetrating Keratoplasty
  • Endothelial Keratoplasty

 

 

           End User

  • Hospitals
  • Ophthalmic Centers
  • Ambulatory Surgical Clinics

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of corneal implants is estimated at USD 494.61 million.

Corneal Implants Market size was valued at USD 468.34 million in 2024 and is likely to cross USD 1.07 billion by 2037, expanding at more than 6.6% CAGR during the forecast period i.e., between 2025-2037.

North America industry is likely to dominate majority revenue share by 2037, owing to large number of manufacturers for corneal implant devices, and increasing research and development activities bringing significant innovative procedures

The major players in the market are AJL Ophthalmic SA, CorneaGen, Aurolab, DIOPTEX, Florida Lions Eye Bank, KeraMed, Inc., among others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos